These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 23305360)

  • 1. Direct and indirect antimicrobial activities of neuropeptides and their therapeutic potential.
    Augustyniak D; Nowak J; Lundy FT
    Curr Protein Pept Sci; 2012 Dec; 13(8):723-38. PubMed ID: 23305360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammalian Neuropeptides as Modulators of Microbial Infections: Their Dual Role in Defense versus Virulence and Pathogenesis.
    Augustyniak D; Kramarska E; Mackiewicz P; Orczyk-Pawiłowicz M; Lundy FT
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33915818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of immunomodulatory host defense peptides as novel anti-infectives.
    Easton DM; Nijnik A; Mayer ML; Hancock RE
    Trends Biotechnol; 2009 Oct; 27(10):582-90. PubMed ID: 19683819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptides: keeping the balance between pathogen immunity and immune tolerance.
    Gonzalez-Rey E; Ganea D; Delgado M
    Curr Opin Pharmacol; 2010 Aug; 10(4):473-81. PubMed ID: 20399708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human defensins: turning defense into offense?
    de Leeuw E; Lu W
    Infect Disord Drug Targets; 2007 Mar; 7(1):67-70. PubMed ID: 17346213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial peptides versus invasive infections.
    Yeaman MR; Bayer AS
    Curr Top Microbiol Immunol; 2006; 306():111-52. PubMed ID: 16909920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance: A multifaceted problem with multipronged solutions.
    Gil-Gil T; Laborda P; Sanz-García F; Hernando-Amado S; Blanco P; Martínez JL
    Microbiologyopen; 2019 Nov; 8(11):e945. PubMed ID: 31724836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial Therapy in the Context of the Damage-Response Framework: the Prospect of Optimizing Therapy by Reducing Host Damage.
    Pirofski LA; Casadevall A
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31740558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial Peptides: An Emerging Category of Therapeutic Agents.
    Mahlapuu M; Håkansson J; Ringstad L; Björn C
    Front Cell Infect Microbiol; 2016; 6():194. PubMed ID: 28083516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host defense peptides for use as potential therapeutics.
    Zhang L; Falla TJ
    Curr Opin Investig Drugs; 2009 Feb; 10(2):164-71. PubMed ID: 19197794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immune properties of selected human neuropeptides against Moraxella catarrhalis and nontypeable Haemophilus influenzae.
    Augustyniak D; Jankowski A; Mackiewicz P; Skowyra A; Gutowicz J; Drulis-Kawa Z
    BMC Immunol; 2012 May; 13():24. PubMed ID: 22551165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial Peptides: Vestiges of Past or Modern Therapeutics?
    Mitra JB; Sharma VK; Kumar M; Mukherjee A
    Mini Rev Med Chem; 2020; 20(3):183-195. PubMed ID: 31774045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial Properties and Efficacy of a Novel SPLUNC1-Derived Antimicrobial Peptide, α4-Short, in a Murine Model of Respiratory Infection.
    Jiang S; Deslouches B; Chen C; Di ME; Di YP
    mBio; 2019 Apr; 10(2):. PubMed ID: 30967458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic peptides: new arsenal against drug resistant pathogens.
    Mok WW; Li Y
    Curr Pharm Des; 2014; 20(5):771-92. PubMed ID: 23688084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulators as adjuvants for vaccines and antimicrobial therapy.
    Nicholls EF; Madera L; Hancock RE
    Ann N Y Acad Sci; 2010 Dec; 1213():46-61. PubMed ID: 20946578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptides as pleiotropic modulators of the immune response.
    Souza-Moreira L; Campos-Salinas J; Caro M; Gonzalez-Rey E
    Neuroendocrinology; 2011; 94(2):89-100. PubMed ID: 21734355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiome as a tool and a target in the effort to address antimicrobial resistance.
    Relman DA; Lipsitch M
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):12902-12910. PubMed ID: 30559176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial Peptides and Innate Lung Defenses: Role in Infectious and Noninfectious Lung Diseases and Therapeutic Applications.
    Hiemstra PS; Amatngalim GD; van der Does AM; Taube C
    Chest; 2016 Feb; 149(2):545-551. PubMed ID: 26502035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormesis and Defense of Infectious Disease.
    Weis S; Rubio I; Ludwig K; Weigel C; Jentho E
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28617331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Immune System of Marine Organisms as Source for Drugs against Infectious Diseases.
    Falco A; Adamek M; Pereiro P; Hoole D; Encinar JA; Novoa B; Mallavia R
    Mar Drugs; 2022 May; 20(6):. PubMed ID: 35736166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.